2026 MVP Pulmonology Care (ID: M1424)

MVP ID: M1424

Most applicable medical specialty(s):
Pulmonology, Sleep Medicine, Nonphysician Practitioners, Nurse Practitioner, Physician Assistants

The Pulmonology Care MVP focuses on assessing optimal care for patients treated for a broad range of pulmonology conditions including COPD, asthma, sleep apnea, and general pulmonology.

Quality

• Quality ID: 047: Advance Care Plan
• Quality ID: 052: Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting Inhaled Bronchodilator Therapy
• Quality ID: 128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
• Quality ID: 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
• Quality ID: 277: Sleep Apnea: Severity Assessment at Initial Diagnosis
• Quality ID: 279: Sleep Apnea: Assessment of Adherence to Obstructive Sleep Apnea (OSA) Therapy.
• Quality ID: 398: Optimal Asthma Control
• Quality ID: 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months
• Quality ID: ACEP25: Tobacco Use: Screening and Cessation Intervention for Patients with Asthma and COPD

Improvement Activities

Report one improvement activity from the list below:

• IA_AHW_1: Chronic Care and Preventative Care Management for Empaneled Patients
• IA_BE_23: Integration of patient coaching practices between visits
• IA_BE_26: Promote Use of Patient-Reported Outcome Tools
• IA_CC_9: Implementation of practices/processes for developing regular individual care plans
• IA_EPA_2: Use of telehealth services that expand practice access
• IA_MVP: Practice-Wide Quality Improvement in MIPS Value Pathways - High
• IA_PCMH: Electronic submission of Patient Centered Medical Home accreditation
• IA_PM_16: Implementation of medication management practice improvements

Cost

Calculated by CMS using administrative claims data:

• Measure ID: COST_COPDE_1 - Inpatient Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
• Measure ID: COST_ACOPD_1 - Asthma/Chronic Obstructive Pulmonary Disease (COPD)

Population Health Measures

CMS will calculate both population health measures using administrative claims data (if case minimum requirements are met) and assign the higher of these measures to the Quality score. If neither of the population health measures can be calculated, they will be excluded from scoring.

• #479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment Program (MIPS) Groups (Administrative Claims)(!!)
• #484: Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (Administrative Claims) (!!)

Promoting Interoperability

Report on the same PI measures required under traditional MIPS unless qualified for automatic reweighting or approved hardship exception:

• Actions to Limit or Restrict Compatibility or Interoperability of CEHRT Attestation
• e-Prescribing
• Query of the Prescription Drug Monitoring Program (PDMP)
• Provide Patients Electronic Access to Their Health Information
• Support Electronic Referral Loops By Sending Health Information AND
• Support Electronic Referral Loops By Receiving and Reconciling Health Information OR
• Health Information Exchange (HIE) Bi-Directional Exchange
• Enabling Exchange Under the Trusted Exchange Framework and Common Agreement (TEFCA)
• Immunization Registry Reporting
• Syndromic Surveillance Reporting
• Electronic Case Reporting
• Public Health Registry Reporting
• Clinical Data Registry Reporting
• Security Risk Analysis
• Safety Assurance Factors for EHR Resilience Guide (SAFER Guide)
• ONC Direct Review Attestation

MVP Registration

• MVP Participants must register between April 1 – December 1, 2026 to report an MVP in 2026.
• To register, MVP Participants must select:
  • The MVP they intend to report.
  • Any outcomes-based administrative claims measures on which the MVP Participant intends to be scored (if available).
  • Whether they plan to administer the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Survey, if it’s a quality measure option in the selected MVP.
  • The participation option they plan to use: individual, group, subgroup, or APM Entity.
  • Starting in 2026, to register for MVP reporting as a group, the practice will need to attest to their specialty composition (whether they are a single specialty group or multispecialty small practice) during the MVP registration process. CMS won't make this determination for the practice. All other groups will need to participate as subgroups or as individuals (if eligible) to report an MVP. 
• If reporting as a subgroup, registration must also include:
  • A list of Taxpayer Identification Numbers (TINs)/National Provider Identifiers (NPIs) in the subgroup;
  • A plain language name for the subgroup (which will be used for public reporting);
  • A description of the composition of the subgroup, which may be selected from a list or described in a narrative.
• MVP Participants won’t be able to:
  • Submit/make changes to the MVP they select after the close of the registration period (December 1, 2026).
  • Report on an MVP they didn’t register for during the 2026 performance year.
  • Report on more than one MVP.